Press release
Auto Injectors Market to Exceed US$2.5 bn by 2020 Led by Demand for Pre-filled Auto Injectors
Read Report Overview @ https://www.transparencymarketresearch.com/global-auto-injectors-market.html
The study states that the global auto-injectors market will rise from its 2013 valuation of US$665.0 mn to rise to US$2.5 bn by 2020, with enormous opportunities existing in RoW markets and emerging economies. An alarming increase in the prevalence of rheumatoid arthritis and various food allergies will further create opportunities for the growth of the auto injectors market globally. TMR analysts identify a major roadblock standing in the way of companies trying to occupy a larger revenue share in the auto-injectors market: The high prices of auto-injectors. The price factor assumes greater importance when it comes to patients in emerging economies, where, incidentally, the most lucrative growth opportunities lie.
Request Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4199
Even so, the demand for auto injectors will continue to rise consistently as patients opt to choose these products for their ease of use, even during self-administration. The report segments the global auto injectors market on the basis of product type, manufacturing design, therapeutic application, and geography. On the basis of product type, the market is segmented into prefilled or disposable auto injectors and fillable or reusable auto injectors. Given their unmatched ease of use, pre-filled auto injectors made up the largest segment in the auto injectors market by product type.
Likewise, using manufacturing design as a criterion, the global auto-injectors market has been segmented into customized and standardized auto injectors. Although the standardized injectors segment was the larger one in 2013, the growth of the customized auto-injectors segment will be the fastest through the report’s forecast period.Moving further, the report segments the auto-injectors market by therapeutic application into anaphylaxis, rheumatoid arthritis, multiple sclerosis, and others. The high prevalence of anaphylaxis has created a massive demand for auto injectors for administrating drugs to people suffering from this condition. This factor has made the anaphylaxis the largest application segment in the auto injectors market.
Request Auto-Injectors Market Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4199
From the geographical standpoint, the market for auto injectors is segmented into North America, Asia Pacific, Europe, and Rest of the World (RoW). Claiming a 70% stake in the global auto-injectors market, North America was seen to be the largest regional market in 2013. While the dominant position of North America will not see a drastic change, the Asia Pacific market will report the fastest rate of growth. The key recommendations of TMR’s analysts, discussed in detail in the report, include: Channeling investments into China and India, spearheading innovation in auto injectors, and improving consumer awareness through marketing campaigns.
Companies profiled in detail in the auto-injectors market report include: Pfizer, Inc., Becton, Dickinson & Co., Mylan, Inc., Antares Pharma Inc., Novartis International AG, Unilife Corp., Ypsomed Holding AG, Biogen Idec, and Scandinavian Health Ltd.
Buy Full Auto-Injectors Market Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=4199<ype=S
About TMR
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Auto Injectors Market to Exceed US$2.5 bn by 2020 Led by Demand for Pre-filled Auto Injectors here
News-ID: 827651 • Views: …
More Releases from TMR - Research Reports
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during…
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the…
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016.
The global dental membrane and bone graft substitutes market is expected to…
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period.
By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment…
More Releases for US$2
Pulse Protein Market to Cross US$ 2 Bn by 2030
Pulse-based protein is linked with many benefits such as lower risk of stroke, cancer, and death from heart disease. Pulse protein also has essential amino acids, as compared to animal protein. Animal protein contains a high amount of saturated fat and dietary cholesterol, which increases heart diseases. Pulse proteins are healthy and delicious meat-free food, ideal for vegetarians and personal wellbeing. The global pulse protein market has witnessed substantial growth…
N-Methyl-2-Pyrrolidone Market worth US$ 2 Billion by 2027
N-Methyl-2-Pyrrolidone Market: Key Highlights
The N-methyl-2-pyrrolidone (NMP) market was valued at ~US$ 1.1 Bn in 2018, and is anticipated to expand at a CAGR of ~6.0% from 2019 to 2027.
The global N-methyl-2-pyrrolidone market is driven by the rise in the demand for N-methyl-2-pyrrolidone from the electronics industry.
In terms of value, the N-methyl-2-pyrrolidone market in Asia Pacific is expected to expand at a CAGR of ~8% during the forecast period. China is…
N-Methyl-2-Pyrrolidone in Cosmetics worth US$ 2 Billion by 2027
N-Methyl-2-Pyrrolidone Market Holds Multichannel Revenue Opportunities
The sales of consumer electronics are showing no signs of slowing down, implying that, manufacturers of electronic devices are investing toward the development of smart-sized products with better functionalities, which manages to attract the attention of consumers.
Read report Overview-
https://www.transparencymarketresearch.com/n-methyl-2-pyrrolidone-nmpo-market.html
Investments made in the consumer electronics market, are, in turn, creating opportunities for the N-methyl-2-pyrrolidone market, given the rising demand for lithium batteries. According to stats published…
Blockchain Certification Company Lands US $2 Million Investment
Blockchain is growing, the crypto markets are booming but a serious problem which has now started hurting the whole industry is the involvement of a limited number of people who are currently running the show. More than blockchain literacy, we have developers, traders and investors who are driven by misinformation as there is no set standard in the industry to follow.
The whole blockchain is based on open source code and…
2-Methylresorcinol Market will reach 83 million US$ in 2023
New report published by Global Info Research which offers insights on the global 2-Methylresorcinol market.
2-Methylresorcinol is a slightly yellow crystalline powder. In cosmetics and personal care products, both Resorcinol and 2-Methylresorcinol are typically used in the formulation of hair dyes and colors. Resorcinol is also used in other hair and skin care products.
Click…
Liquid Biopsy Market Worth US$ 2 Billion by 2022
New York, April 24: Market Research Engine has published a new report titled as “Liquid Biopsy Market By Type of Cancer Analysis (Lung Cancer, Colorectal Cancer, Prostate Cancer, Breast Cancer, Liver Cancer); By Product and services Analysis (Instruments, Services and Software, Reagents); By Circulation Biomarkers Analysis (Circulating Tumor Cells (CTCs), Extracellular Vesicles (EVs), Circulating Tumor DNA (ctDNA)); By End User Analysis (academic & Research Centers, Reference Laboratories, Hospital and Physician…
